160 gd conjugated mouse anti human cd14 (fluidigm)
Structured Review

160 Gd Conjugated Mouse Anti Human Cd14, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 14 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human+cd14+160/Anti-Human+CD14+(RMO52)-160Gd/pmc12583509-58-0-6
Average 93 stars, based on 14 article reviews
Images
1) Product Images from "Systems approach identifies monocyte imbalance in symptomatic and asymptomatic P. vivax malaria"
Article Title: Systems approach identifies monocyte imbalance in symptomatic and asymptomatic P. vivax malaria
Journal: Molecular Systems Biology
doi: 10.1038/s44320-025-00135-z
Figure Legend Snippet: Peripheral blood mononuclear cells from P. vivax symptomatic ( n = 8), asymptomatic ( n = 8), and healthy controls ( n = 8) were stained with a panel of metal-labeled antibodies and analyzed CyTOF. ( A ) Manual gating was used to select for CD14 + monocytes. ( B ) vi-SNE analysis was performed on pooled monocytes for each group and the cell surface expression was illustrated by their density.
Techniques Used: Staining, Labeling, Expressing
Figure Legend Snippet: ( A – F ) PBMCs from P. vivax symptomatic ( n = 8) and asymptomatic ( n = 8) infected individuals as well as healthy immune controls ( n = 8) were stained with a panel of metal-labeled antibodies and analyzed by CyTOF. ( A ) t-SNE analysis was performed on CD14 + CD3 - CD29 - monocytes. Plots display cell density and represent the pooled data for each group. ( B ) Projection of FlowSOM clusters on a t-SNE plot. ( C ) Heatmaps show the median marker expression for each FlowSOM cluster. ( D – F ) Unsupervised identification of differentially abundant populations between clinical groups was performed using CITRUS (FDR < 5%) between clinical groups. Panels on the top left or each panel show differentially abundant populations on a t-SNE overlay identified as follows: significantly more abundant in symptomatic individuals compared to healthy immune controls ( D ), significantly more abundant in symptomatic and asymptomatic individuals compared to healthy immune controls ( E ) and significantly depleted in symptomatic and asymptomatic individuals compared to healthy immune controls ( F ). vi-SNE plots on the top right-hand side or each top panel depict relevant marker expression on t-SNE overlays. The lower left panels show the frequency of differentially abundant cell populations identified by CITRUS. Boxes represent the 25th to 75th percentile, whiskers show the range (minimum to maximum), and lines represent the median of 8 symptomatic, 8 asymptomatic, and 8 healthy immune control biological replicates. The lower right panels illustrate marker expression in differentially abundant populations (pink histograms), relative to background expression (lilac histograms).
Techniques Used: Infection, Staining, Labeling, Marker, Expressing, Control
Related Articles
Staining:Article Title: Stratification of Adult Glioblastoma with Signaling and Single Cell Biology Article Snippet: The cells were washed and resuspended in staining medium [CSM: PBS + 1% BSA (Fisher Scientific, Fair Lawn, NJ)]. .. Cells were then stained with a mass cytometry antibody panel of 29 extracellular antibodies designed to characterize AML blasts and most non-AML peripheral blood mononuclear cells consisting of anti-human CD235a-141 (clone HIR2, Fluidigm), anti-human CD117-143 (clone 104D2, Fluidigm), anti-human CD11b-144 (clone ICRF 44, Fluidigm), anti-human CD4-145 (clone RPAT4, Fluidigm), anti-human CD64-146 (clone 10.1, Fluidigm), anti-human CD36-147 (clone 5-271, BioLegend), anti- human CD34-148 (clone 581, Fluidigm), anti-human CCR2-149 (clone KO36C2, BioLegend), anti-human CD43- 150 (clone 84-3C1, Fluidigm), antihuman CD123-151 (clone 6H6, Fluidigm), anti-human CD13-152 (clone WM15, Fluidigm), anti-human CD45RA-153 (clone HI100, Fluidigm), anti-human CD45-154 (clone HI30, Fluidigm), anti-human CD86-156 (clone IT2.2, Fluidigm), antihuman CD33-158 (clone WM53, Fluidigm), anti- human CD11c-159 (clone BU15, Fluidigm), Article Title: Discovery of human cell selective effector molecules using single cell multiplexed activity metabolomics Article Snippet: The cells were washed and resuspended in staining medium [CSM: PBS + 1% BSA (Fisher Scientific, Fair Lawn, NJ)]. .. Cells were then stained with a mass cytometry antibody panel of 29 extracellular antibodies designed to characterize AML blasts and most non-AML peripheral blood mononuclear cells consisting of anti-human CD235a-141 (clone HIR2, Fluidigm), anti-human CD117-143 (clone 104D2, Fluidigm), anti-human CD11b-144 (clone ICRF44, Fluidigm), anti-human CD4-145 (clone RPAT4, Fluidigm), anti-human CD64-146 (clone 10.1, Fluidigm), anti-human CD36-147 (clone 5-271, BioLegend), anti-human CD34-148 (clone 581, Fluidigm), anti-human CCR2-149 (clone K036C2, BioLegend), anti-human CD43-150 (clone 84-3C1, Fluidigm), anti-human CD123-151 (clone 6H6, Fluidigm), anti-human CD13-152 (clone WM15, Fluidigm), anti-human CD45RA-153 (clone HI100, Fluidigm), anti-human CD45-154 (clone HI30, Fluidigm), anti-human CD86-156 (clone IT2.2, Fluidigm), anti-human CD33-158 (clone WM53, Fluidigm), anti-human CD11c-159 (clone BU15, Fluidigm), Mass Cytometry:Article Title: Stratification of Adult Glioblastoma with Signaling and Single Cell Biology Article Snippet: The cells were washed and resuspended in staining medium [CSM: PBS + 1% BSA (Fisher Scientific, Fair Lawn, NJ)]. .. Cells were then stained with a mass cytometry antibody panel of 29 extracellular antibodies designed to characterize AML blasts and most non-AML peripheral blood mononuclear cells consisting of anti-human CD235a-141 (clone HIR2, Fluidigm), anti-human CD117-143 (clone 104D2, Fluidigm), anti-human CD11b-144 (clone ICRF 44, Fluidigm), anti-human CD4-145 (clone RPAT4, Fluidigm), anti-human CD64-146 (clone 10.1, Fluidigm), anti-human CD36-147 (clone 5-271, BioLegend), anti- human CD34-148 (clone 581, Fluidigm), anti-human CCR2-149 (clone KO36C2, BioLegend), anti-human CD43- 150 (clone 84-3C1, Fluidigm), antihuman CD123-151 (clone 6H6, Fluidigm), anti-human CD13-152 (clone WM15, Fluidigm), anti-human CD45RA-153 (clone HI100, Fluidigm), anti-human CD45-154 (clone HI30, Fluidigm), anti-human CD86-156 (clone IT2.2, Fluidigm), antihuman CD33-158 (clone WM53, Fluidigm), anti- human CD11c-159 (clone BU15, Fluidigm), Article Title: Discovery of human cell selective effector molecules using single cell multiplexed activity metabolomics Article Snippet: The cells were washed and resuspended in staining medium [CSM: PBS + 1% BSA (Fisher Scientific, Fair Lawn, NJ)]. .. Cells were then stained with a mass cytometry antibody panel of 29 extracellular antibodies designed to characterize AML blasts and most non-AML peripheral blood mononuclear cells consisting of anti-human CD235a-141 (clone HIR2, Fluidigm), anti-human CD117-143 (clone 104D2, Fluidigm), anti-human CD11b-144 (clone ICRF44, Fluidigm), anti-human CD4-145 (clone RPAT4, Fluidigm), anti-human CD64-146 (clone 10.1, Fluidigm), anti-human CD36-147 (clone 5-271, BioLegend), anti-human CD34-148 (clone 581, Fluidigm), anti-human CCR2-149 (clone K036C2, BioLegend), anti-human CD43-150 (clone 84-3C1, Fluidigm), anti-human CD123-151 (clone 6H6, Fluidigm), anti-human CD13-152 (clone WM15, Fluidigm), anti-human CD45RA-153 (clone HI100, Fluidigm), anti-human CD45-154 (clone HI30, Fluidigm), anti-human CD86-156 (clone IT2.2, Fluidigm), anti-human CD33-158 (clone WM53, Fluidigm), anti-human CD11c-159 (clone BU15, Fluidigm), |
